Archetype Therapeutics
The AI engine Fit Assessment
BetaArchetype effectively utilizes machine learning for drug discovery, pattern discovery in patient data, and has a proven track record in expanding therapeutics through drug repurposing.
Blurb
Archetype Therapeutics is an AI-native biotech firm specializing in computational drug discovery and repurposing.
HQ Location
United States
Founded
2022
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
- Drug Repurposing
Operator of a drug discovery platform intended to leverage artificial intelligence for patient-specific medicine. The company offers a new approach to drug discovery using AI and patient data to build computer models that identify promising drug candidates, enabling customers to screen billions of molecules to find the effective treatments and improve patient outcomes.